Bi
BioHaven (Pfizer)
New Haven CTFounded 2013500 employees
Private CapbiotechAcquiredNeurologyCNS
Platform: Nurtec CGRP
Market Cap
N/A
All Drugs
3
Clinical Trials
4
Failed / Terminated
1
FDA Approved
1
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Zorizumab | BIO-1403 | Phase 1/2 | 2 | EGFR | MGGA | ||
| Olpanaritide | BIO-6329 | Phase 2/3 | 1 | CGRP | HNSCCHemophilia A | ||
| Zorisertib | BIO-873 | Approved | 1 | SHP2 | RSVParkinson's |
Financial Documents
This company has been acquired — see parent company for financial filings.
Catalyst Events (3)